Cargando…

Development and Evaluation of a Pilot Nurse Case Management Model to Address Multidrug-Resistant Tuberculosis (MDR-TB) and HIV in South Africa

SETTING: Multidrug-resistant tuberculosis (MDR-TB) unit in KwaZulu-Natal, South Africa. OBJECTIVE: To develop and evaluate a nurse case management model and intervention using the tenets of the Chronic Care Model to manage treatment for MDR-TB patients with a high prevalence of human immunodeficienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Farley, Jason E., Kelly, Ana M., Reiser, Katrina, Brown, Maria, Kub, Joan, Davis, Jeane G., Walshe, Louise, Van der Walt, Martie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236054/
https://www.ncbi.nlm.nih.gov/pubmed/25405988
http://dx.doi.org/10.1371/journal.pone.0111702
Descripción
Sumario:SETTING: Multidrug-resistant tuberculosis (MDR-TB) unit in KwaZulu-Natal, South Africa. OBJECTIVE: To develop and evaluate a nurse case management model and intervention using the tenets of the Chronic Care Model to manage treatment for MDR-TB patients with a high prevalence of human immunodeficiency virus (HIV) co-infection. DESIGN: A quasi-experimental pilot programme utilizing a nurse case manager to manage care for 40 hospitalized MDR-TB patients, 70% HIV co-infected, during the intensive phase of MDR-TB treatment. Patients were followed for six months to compare proximal outcomes identified in the model between the pre- and post-intervention period. RESULTS: The greatest percent differences between baseline and six-month MDR-TB proximal outcomes were seen in the following three areas: baseline symptom evaluation on treatment initiation (95% improvement), baseline and monthly laboratory evaluations completed per guidelines (75% improvement), and adverse drug reactions acted upon by medical and/or nursing intervention (75% improvement). CONCLUSION: Improvements were identified in guideline-based treatment and monitoring of adverse drug reactions following implementation of the nurse case management intervention. Further study is required to determine if the intervention introduced in this model will ultimately result in improvements in final MDR-TB treatment outcomes.